Key Points Question What is the effectiveness of respiratory syncytial virus (RSV) vaccines against RSV-associated outcomes for US Medicare beneficiaries aged 65 years or older who resided in nursing homes during September 2023 to March 2024?
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Yangping
Contact Yangping, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack